Sofinnova Investments, Inc. Catalyst Pharmaceuticals, Inc. Transaction History

Sofinnova Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.92 - $3.62 $2.98 Million - $5.61 Million	-1,549,552 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$2.81 - $3.78 $279,861 - $376,469	99,595 Added 6.87%	1,549,552 $5.86 Million
Q2 2018 Nov 15, 2018	BUY	$2.26 - $3.84 $2.91 Million - $4.95 Million	1,288,868 Added 800.1%	1,449,957 $4.52 Million
Q2 2018 Aug 14, 2018	BUY	$2.26 - $3.84 $29,456 - $50,050	13,034 Added 8.8%	161,089 $503,000
Q1 2018 May 15, 2018	BUY	$2.39 - $4.01 $353,851 - $593,700	148,055 New	148,055 $354,000

327

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.23B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.